Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Modern Rheumatology|September 28, 2023
Gender differences in patient experience in idiopathic inflammatory myopathies: Subanalysis from the COVAD datasetAkira Yoshida, Minchul Kim, Masataka Kuwana, et al.
Rheumatology (Oxford, England)|May 25, 2023
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey studyNelly Ziade, Marc Aoude, Ihsane Hmamouchi, et al.
Rheumatology International|March 31, 2023
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) surveyR Naveen, Darpan R Thakare, Masataka Kuwana, et al.
Muscle & Nerve|July 23, 2022
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathiesAlbert Gil-Vila, Naveen Ravichandran, Albert Selva-O'Callaghan, et al.
International Journal of Rheumatic Diseases|March 5, 2023
Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD studySamuel Katsuyuki Shinjo, Minchul Kim, Leonardo Santos Hoff, et al.
Rheumatology International|September 5, 2023
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported surveySakir Ahmed, Latika Gupta, Masataka Kuwana, et al.
Rheumatology International|August 14, 2022
COVAD survey 2 long-term outcomes: unmet need and protocolZoha Zahid Fazal, Parikshit Sen, Mrudula Joshi, et al.
Rheumatology Advances in Practice|March 25, 2024
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-surveyAkira Yoshida, Yuan Li, Vahed Maroufy, et al.
Rheumatology International|October 22, 2022
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) surveyLeonardo Santos Hoff, Naveen Ravichandran, Samuel Katsuyuki Shinjo, et al.
Rheumatology (Oxford, England)|March 24, 2023
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveysKshitij Jagtap, R Naveen, Jessica Day, et al.
Pageof 15